Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Pentolinijum

Izvor: Wikipedija
Pentolinijum
Klinički podaci
AHFS/Drugs.comMonografija
Identifikatori
CAS broj52-62-0
ATC kodnije dodeljen
PubChem[1][2]5850
DrugBankDB01090
ChemSpider[3]5641
ChEMBL[4]CHEMBL1271 DaY
Hemijski podaci
FormulaC15H32N2 
Mol. masa240,428
SMILESeMolekuli &PubHem
InChI
InChI=1S/C15H32N2/c1-16(12-6-7-13-16)10-4-3-5-11-17(2)14-8-9-15-17/h3-15H2,1-2H3/q+2
Key: XSBSKEQEUFOSDD-UHFFFAOYSA-N DaY
Fizički podaci
Tačka topljenja213 °C (415 °F)
Farmakoinformacioni podaci
Trudnoća?
Pravni status

Pentolinijum jeorgansko jedinjenje, koje sadrži 15atomaugljenika i imamolekulsku masu od 240,428Da.[5][6]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika0
Broj donora vodonika0
Broj rotacionih veza6
Particioni koeficijent[7] (ALogP)-0,2
Rastvorljivost[8] (logS, log(mol/L))-7,0
Polarna površina[9] (PSA,Å2)0,0

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682. 
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412. 
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. 
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. 

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Pentolinijum naWikimedijinoj ostavi
Simpatolitici
(antagonizirajuα-adrenergičku
vazokonstrikciju)
Centralni
Inhibitori otpuštanja adrenalina
Periferalni
Indirektni
Direktni
Neselektivni α blokator
Drugiantagonisti
dualni (Bosentan) *selektivni (Ambrisentan,Sitaksentan)
Izvor:https://sh.wikipedia.org/w/index.php?title=Pentolinijum&oldid=42275018
Kategorije:
Sakrivena kategorija:

[8]ページ先頭

©2009-2025 Movatter.jp